Moleculin Biotech is trading at $0.43, up +5.03% from the August 7, 2026 close of $0.41, amid positive blinded MIRACLE AML data.
- No new company announcement dated August 10, 2026 was identified.
- A $9.3 million public offering was announced July 31, 2026.
- Broader markets are mixed, offering no clear market-wide explanation.